Familial tumor endocrinopathies.
The spectrum of familial tumor endocrinopathies is broad; what has been described here probably represents only a small part of the entire subject. No consideration has been given to treatment, as this is covered in standard tests. It is important to recognize that, potentially, any endocrine tumor may be familial, and both a detailed family study and longitudinal follow-up are necessary if the mode of inheritance and the degree of clinical variability are to be established with certainty.
D000231:Adenocarcinoma, Papillary / Q000235:genetics; D007516:Adenoma, Islet Cell / Q000235:genetics*; D000306:Adrenal Cortex Neoplasms / Q000145:classification / Q000235:genetics; D000310:Adrenal Gland Neoplasms / Q000235:genetics*; D002276:Carcinoid Tumor / Q000235:genetics; D002277:Carcinoma / Q000235:genetics / Q000473:pathology; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000235:genetics; D005799:Genes, Dominant; D006801:Humans; D008297:Male; D008875:Middle Aged; D009377:Multiple Endocrine Neoplasia / Q000145:classification; D010051:Ovarian Neoplasms / Q000235:genetics*; D010190:Pancreatic Neoplasms / Q000235:genetics*; D010282:Parathyroid Neoplasms / Q000235:genetics*; D010673:Pheochromocytoma / Q000235:genetics; D010871:Pinealoma / Q000235:genetics*; D010911:Pituitary Neoplasms / Q000235:genetics*; D012730:Sex Chromosomes; D013736:Testicular Neoplasms / Q000235:genetics*; D013964:Thyroid Neoplasms / Q000235:genetics* / Q000473:pathology